{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:46:28Z","timestamp":1791135988095,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.ijrobp.2011.03.008","type":"journal-article","created":{"date-parts":[[2011,5,25]],"date-time":"2011-05-25T16:52:22Z","timestamp":1306342342000},"page":"e407-e413","source":"Crossref","is-referenced-by-count":10,"title":["Early Choline Levels From 3-Tesla MR Spectroscopy After Exclusive Radiation Therapy in Patients With Clinically Localized Prostate Cancer are Predictive of Plasmatic Levels of PSA at 1 Year"],"prefix":"10.1016","volume":"81","author":[{"given":"Gilles","family":"Crehange","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Maingon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Parfait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Cochet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Mirjolet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Bonnetain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Cormier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Brunotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2011.03.008_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0090-4295(02)02268-9","article-title":"Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy: Prostate-specific antigen","volume":"61","author":"Freedland","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2011.03.008_bib2","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0022-5347(17)32394-7","article-title":"The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy","volume":"152","author":"Trapasso","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2011.03.008_bib3","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1557::AID-CNCR24>3.0.CO;2-2","article-title":"Defining biochemical cure for prostate carcinoma patients treated with external beam radiation therapy","volume":"86","author":"Kestin","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2011.03.008_bib4","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.ijrobp.2008.12.067","article-title":"Postradiotherapy 2-year prostate-specific antigen nadir as a predictor of long-term prostate cancer mortality","volume":"75","author":"Zelefsky","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2011.03.008_bib5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1148\/radiol.2451061444","article-title":"Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: Feasibility","volume":"245","author":"Scheenen","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2011.03.008_bib6","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/mrm.1302","article-title":"Dualband spectral-spatial RF pulses for prostate MR spectroscopic imaging","volume":"46","author":"Schricker","year":"2001","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.ijrobp.2011.03.008_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/(SICI)1522-2594(200001)43:1<23::AID-MRM4>3.0.CO;2-E","article-title":"Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer","volume":"43","author":"Tran","year":"2000","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.ijrobp.2011.03.008_bib8","doi-asserted-by":"crossref","unstructured":"Crehange G, Parfait S, Liegard M, et\u00a0al. Tumor volume and metabolism of prostate cancer determined by proton magnetic resonance spectroscopic imaging at 3T without endorectal coil reveal potential clinical implications in the context of radiation oncology. Int J Radiat Oncol Biol Phys. In press.","DOI":"10.1016\/j.ijrobp.2010.03.007"},{"key":"10.1016\/j.ijrobp.2011.03.008_bib9","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.urology.2006.08.1056","article-title":"Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure","volume":"68","author":"Ray","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2011.03.008_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/cncr.22341","article-title":"Prostate-specific antigen nadir within 12 months of prostate cancer radiotherapy predicts metastasis and death","volume":"109","author":"Alcantara","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2011.03.008_bib11","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0022-5347(01)61631-8","article-title":"Prostate specific antigen nadir achieved by men apparently cured of prostate cancer by radiotherapy","volume":"161","author":"Critz","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2011.03.008_bib12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0360-3016(02)02717-7","article-title":"Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer","volume":"53","author":"Hanlon","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2011.03.008_bib13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ijrobp.2009.10.071","article-title":"A comparison of the prognostic value of early PSA test-based variables following external beam radiotherapy, with or without preceding androgen deprivation: Analysis of data from the TROG 96.01 randomized trial","volume":"79","author":"Lamb","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2011.03.008_bib14","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0022-5347(01)65876-2","article-title":"Prostate specific antigen nadir following external beam radiation therapy for clinically localized prostate cancer: The relationship between nadir level and disease-free survival","volume":"156","author":"Lee","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2011.03.008_bib15","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/annonc\/mdp365","article-title":"Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy","volume":"21","author":"de Crevoisier","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2011.03.008_bib16","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.radonc.2008.10.004","article-title":"PSA response signatures: A powerful new prognostic indicator after radiation for prostate cancer?","volume":"90","author":"Denham","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2011.03.008_bib17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ijrobp.2007.03.031","article-title":"PSA kinetics and PSA bounce following permanent seed prostate brachytherapy","volume":"69","author":"Crook","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2011.03.008_bib18","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0360-3016(01)01557-7","article-title":"Patterns and fate of PSA bouncing following 3D-CRT","volume":"50","author":"Hanlon","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2011.03.008_bib19","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/cncr.22183","article-title":"Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: A multiinstitutional pooled analysis","volume":"107","author":"Horwitz","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2011.03.008_bib20","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0360-3016(02)04470-X","article-title":"Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: Descriptions and implications","volume":"56","author":"Stock","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2011.03.008_bib21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.brachy.2006.02.003","article-title":"PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure: A study of 295 patients with a minimum 3-year followup","volume":"5","author":"Toledano","year":"2006","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2011.03.008_bib22","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1148\/radiology.219.3.r01jn46817","article-title":"Brachytherapy for prostate cancer: Endorectal MR imaging of local treatment-related changes","volume":"219","author":"Coakley","year":"2001","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2011.03.008_bib23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1148\/radiol.2332032086","article-title":"Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: Preliminary experience","volume":"233","author":"Coakley","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2011.03.008_bib24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ijrobp.2008.04.056","article-title":"Pretreatment endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging features of prostate cancer as predictors of response to external beam radiotherapy","volume":"73","author":"Joseph","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2011.03.008_bib25","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.ijrobp.2004.05.015","article-title":"Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer","volume":"60","author":"Pickett","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2011.03.008_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijrobp.2005.11.037","article-title":"Three-dimensional conformal external beam radiotherapy compared with permanent prostate implantation in low-risk prostate cancer based on endorectal magnetic resonance spectroscopy imaging and prostate-specific antigen level","volume":"65","author":"Pickett","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2011.03.008_bib27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ijrobp.2009.10.066","article-title":"3D MR-spectroscopic imaging assessment of metabolic activity in the prostate during the PSA \u201cbounce\u201d following (125)Iodine brachytherapy","volume":"79","author":"Kirilova","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301611004652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301611004652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T05:34:41Z","timestamp":1560231281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301611004652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0360301611004652"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2011.03.008","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}